Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: Phase 3, Randomized, Placebo-Controlled, ZOE-HSCT Clinical Trial

被引：0

作者：

Sullivan, Keith ^{[1
]}

Abhyankar, Sunil ^{[2
]}

Campora, Laura ^{[3
]}

Cellini, Claudia ^{[4
]}

Chandrasekar, Pranatharthi ^{[5
]}

de la Serna, Javier ^{[6
]}

El Idrissi, Mohamed ^{[3
]}

Gaidano, Gianluca ^{[7
]}

Issa, Nicolas ^{[8
,9
]}

Lee, Je-Jung ^{[10
]}

Fauqued, Marta Lopez ^{[3
]}

Lopez Jimenez, Javier ^{[11
]}

Oostvogels, Lidia ^{[3
]}

Pohlreich, David ^{[12
]}

Quittet, Philippe ^{[13
]}

Schwartz, Stefan ^{[14
]}

Stadtmauer, Edward ^{[15
]}

Szer, Jeff ^{[16
]}

Bastidas, Adriana ^{[3
]}

机构：

[1] Duke Univ, Med Ctr, Durham, NC USA

[2] Univ Kansas, Ctr Canc, Westwood, KS USA

[3] GSK, Wavre, Belgium

[4] Hosp Santa Maria delle Croci, Ravenna, Italy

[5] Wayne State Univ, Detroit, MI USA

[6] Hosp Univ 12 Octubre, Madrid, Spain

[7] Univ Piemonte Orientale, Novara, Italy

[8] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[9] Dana Farber Canc Inst, Boston, MA 02115 USA

[10] Chonnam Natl Univ, Hwasun Hosp, Jellanamdo, South Korea

[11] Ramon & Cajal Hosp, Madrid, Spain

[12] Charles Univ Hosp, Prague, Czech Republic

[13] Univ Hosp Montpellier, Montpellier, France

[14] Charite Univ Med Ctr, Berlin, Germany

[15] Univ Penn, Philadelphia, PA 19104 USA

[16] Royal Melbourne Hosp, Melbourne, Vic, Australia

来源：

BONE MARROW TRANSPLANTATION | 2018年 / 53卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O111

引用

下载

页码：95 / 97

页数：3

共 50 条

[21] A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of Inactivated Vzv Vaccine (ZVIN) in Recipients of Autologous Hematopoietic Cell Transplants (Auto-Hcts)
Winston, Drew J.
Mullane, Kathleen M.
Boeckh, Michael J.
Cornely, Oliver A.
Hurtado, Kimberly
Su, Shu-Chih
Pang, Lei
Zhao, Yanli
Chan, Ivan S. F.
Stek, Jon E.
Kaplan, Susan S.
Parrino, Janie
Annunziato, Paula
Popmihajlov, Zoran
Arvin, Ann
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S22 - S23
[22] Posoleucel for adenovirus infection in pediatric and adult allogeneic hematopoietic cell transplant recipients: Design of a phase 3, randomized, double-blind, placebo-controlled trial
Rao, K.
Myers, G. D.
Fraser, I.
Stoner, E.
Ljungman, P.
BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 293 - 294
[23] Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Eberhardson, Michael
Hall, Stephen
Papp, Kim A.
Sterling, Tina M.
Stek, Jon E.
Pang, Lei
Zhao, Yanli
Parrino, Janie
Popmihajlov, Zoran
CLINICAL INFECTIOUS DISEASES, 2017, 65 (07) : 1174 - 1182
[24] Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single- centre, randomised, double-blind, placebo-controlled trial
Park, Jin Kyun
Kim, Miriam
Jung, Ji In
Kim, Ju Yeon
Jeong, Heejin
Park, Jun Won
Winthrop, Kevin L.
Lee, Eun Bong
LANCET RHEUMATOLOGY, 2024, 6 (06): : e352 - e360
[25] Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial
Wu, Zhi-Wei
Jin, Fei
Li, Qing-Liang
Gao, Jia-Mei
Zhou, Hai-Song
Duan, Kai
Gao, Zhao
Liu, Yan
Hao, Zhi-Yong
Chen, Wei
Liu, Yue-Yue
Xu, Ge-Lin
Yang, Biao
Dong, Ben
Zhang, Jiu-Wei
Zhao, Yu-Liang
Yang, Xiao-Ming
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
[26] Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection
Nell, Andre S.
D'lom, Eva
Bouic, Patrick
Sabate, Montserrat
Bosser, Ramon
Picas, Jordi
Amat, Merce
Churchyard, Gavin
Cardona, Pere-Joan
PLOS ONE, 2014, 9 (02):
[27] Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial
Wang, Yanxia
Zhang, Yuhui
Wu, Haofei
Huang, Lili
Yu, Hailong
Xie, Zhiqiang
Zhang, Huiping
Zhang, Wei
Chen, Xiaofen
Zhang, Huan
Zhang, Hongdong
Jia, Chunyu
Xia, Shengli
Wang, Shuai
VACCINE, 2021, 39 (29) : 3871 - 3878
[28] Phase 3 Randomized, Multicenter, Placebo-Controlled Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of an Adjuvanted Cell Culture-Derived, H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects
Peterson, James
Van Twuijver, Esther
Versage, Eve
Hohenboken, Matthew
VACCINES, 2022, 10 (04)
[29] Prophylaxis against cytomegalovirus with oral maribavir in allogeneic stem cell transplant recipients: results of a phase 3 randomized, double-blind, placebo-controlled trial
Marty, F.
Boeckh, M.
Ljungman, P.
Villano, S.
BONE MARROW TRANSPLANTATION, 2009, 43 : S59 - S59
[30] A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant
Nakamura, Ryotaro
La Rosa, Corinna
Yang, Dongyun
Hill, Joshua A.
Rashidi, Armin
Choe, Hannah
Zhou, Qiao
Lingaraju, Chetan Raj
Kaltcheva, Teodora
Longmate, Jeffrey
Drake, Jennifer
Slape, Cynthia
Duarte, Lupe
Al Malki, Monzr M.
Pullarkat, Vinod A.
Aribi, Ahmed
Devine, Steven
Verneris, Michael R.
Miller, Jeffrey S.
Forman, Stephen J.
Aldoss, Ibrahim
Diamond, Don J.
HAEMATOLOGICA, 2024, 109 (06) : 1994 - 1999

← 1 2 3 4 5 →